Found: 5
Select item for more details and to access through your institution.
Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 6, p. 619, doi. 10.1111/apt.12635
- By:
- Publication type:
- Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.88_2880
- By:
- Publication type:
- Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.87_2880
- By:
- Publication type:
- Article
GENOME WIDE‐ANALYSIS OF T(14;18)‐NEGATIVE FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 144, doi. 10.1002/hon.102_2629
- By:
- Publication type:
- Article
GENOME WIDE‐ANALYSIS OF T(14;18)‐NEGATIVE FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 144, doi. 10.1002/hon.102_2629
- By:
- Publication type:
- Article